Serial Number
78022512
Owner
ExonHit Therapeutics SAAttorney
Martin SavitzkyFiling Date
Aug 23, 2000
PROFILE-HIT Trademark
Serial Number: 78022512
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
August 23, 2000
Registration Date
Not Registered
Published for Opposition
October 22, 2002
Goods & Services
(Based on 44(e)) Computer programs for medical testing, to analyze nucleic acids present in human or animal cells, using nucleic acid arrays on chips and chemical reagents, to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases
(Based on 44(e)) nucleic acid arrays on chips for use in medical research and medical tests permitting the analysis of nucleic acids present in human or animal cells to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases; chemical reagents for medical use
(Based on 44(e)) nucleic acid probes on chips for use in medical research and medical tests permitting the analysis of nucleic acids present in human or animal cells to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases
(Based on Intent to Use) (Based on 44(e)) Medical testing services for analysis of nucleic acids found in human or animal cells to determine the presence of pathologies, namely, cancer and neurodegenerative diseases, or the effect of drugs on such pathologies, namely, cancer and neurodegenerative diseases